http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107033149-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 |
| filingDate | 2017-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107033149-B |
| titleOfInvention | DPP-4 enzyme inhibitor and preparation and application thereof |
| abstract | The invention provides a novel dipeptidyl peptidase 4 (DPP-4) inhibitor and preparation and application thereof, and particularly discloses two types of pyrazolo [1,5-a ] shown as a formula A and a formula B]Pyrimidine- (4H) -ones and pyrazolo [1,5-a]Pyrimidine derivatives, their preparation and use as DPP-4 inhibitors, wherein, the definition of each group is described in the specification. The compound of the invention has good DPP-4 inhibition effect and is used for preparing a pharmaceutical composition for treating diseases such as diabetes. |
| priorityDate | 2017-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 197.